Adrian Galiana-Bordera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Adrian Galiana-Bordera has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Pedro Miguel Martinez-Girones
Biomedical Imaging Research Group (GIBI230), La Fe Health Research Institute (IIS La Fe), Valencia, Spain
4 shared publications - Angel Torrado-Carvajal
Universidad Rey Juan Carlos Medical Image Analysis and Biometry Laboratory Madrid Spain
1 shared publication - Anna Nogué-Infante
Quantitative Imaging Biomarkers in Medicine, Quibim S.L. Avenida Aragón 30 13th floor, office I–J, Valencia, Spain
1 shared publication Antonio Orduña Galán
Information Technology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain
1 shared publication- Antonio Sanz Montemayor
Universidad Rey Juan Carlos
1 shared publication - Borja Rodriguez-Vila
Universidad Rey Juan Carlos Medical Image Analysis and Biometry Laboratory Madrid Spain
1 shared publication
Latest Publications
- Open Access
- 31 July 2026
- Published by Springer Nature in European Radiology Experimental
- Vol. 10 (1) , 111
Bridging the AI chasm in oncology: a standardized platform to enable the in silico clinical validation of AI models within the CHAIMELEON Project
Objective: Artificial intelligence (AI) shows promise for improving cancer management, but clinical adoption is limited by the absence of standardized validation tools. As an important step toward bridging the AI chasm, the European CHAIMELEON project addresses this gap by developing a platform for in silico validation of AI models in oncology, aligned with the EUCAIM project. Materials and methods: We designed a web-based platform using Kubernetes microservices architecture, integrating imaging, clinical, and AI components. The backend combines a REST API, an ORTHANC-PACS, and a Keycloak/OAuth2 security layer. The frontend includes a customized OHIF DICOM viewer for oncological case review. Clinicians evaluated cases across three sequential stages: (1) Standard clinical assessment, (2) Assessment with AI predictions, and (3) Final review against clinical endpoint ground truth. The platform also collects clinicians’ perceptions of AI utility, trust, workflow integration, and usability through a Likert-scale questionnaire. Results: The platform provided efficient access to multimodal data for five cancer types. Clinicians completed structured validations, and survey responses indicated favorable perceptions: 93% found the platform intuitive, over 80% would recommend it, and agreement on AI utility exceeded 40% across most endpoints, indicating a positive reception of the AI as a supportive “second reader” tool that prompts clinical re-evaluation rather than simple consensus. Workflow impact was rated positively, underlining the potential to support clinical decision-making. Conclusion: This platform offers a reproducible, scalable, and user-friendly environment for clinical validation of AI models in oncology. Its modular architecture allows integration of additional AI models and is designed to ensure sustainability and interoperability, fostering evidence-based AI adoption in European radiology practice. Trial registration: ClinicalTrials.gov, NCT06950996. Key Points: How can the medical community standardize the in silico clinical validation of oncology AI models to safely bridge the gap before real-world deployment? We successfully implemented a web-based microservices platform, demonstrating high clinical usability and defining human-AI trust dynamics across five distinct cancer types. This standardized validation framework directly enhances diagnostic confidence and interdisciplinary medical collaboration, bridging technical performance with clinical trust to ensure that innovative artificial intelligence technologies safely optimize daily treatment decisions and ultimately maximize therapeutic success and safety for oncology patients.
- 31 July 2026
- Published by Springer Nature in European Radiology Experimental
- Vol. 10 (1) , 111
Open AccessBridging the AI chasm in oncology: a standardized platform to enable the in silico clinical validation of AI models within the CHAIMELEON Project
Objective: Artificial intelligence (AI) shows promise for improving cancer management, but clinical adoption is limited by the absence of standardized validation tools. As an important step toward bridging the AI chasm, the European CHAIMELEON project addresses this gap by developing a platform for in silico validation of AI models in oncology, aligned with the EUCAIM project. Materials and methods: We designed a web-based platform using Kubernetes microservices architecture, integrating imaging, clinical, and AI components. The backend combines a REST API, an ORTHANC-PACS, and a Keycloak/OAuth2 security layer. The frontend includes a customized OHIF DICOM viewer for oncological case review. Clinicians evaluated cases across three sequential stages: (1) Standard clinical assessment, (2) Assessment with AI predictions, and (3) Final review against clinical endpoint ground truth. The platform also collects clinicians’ perceptions of AI utility, trust, workflow integration, and usability through a Likert-scale questionnaire. Results: The platform provided efficient access to multimodal data for five cancer types. Clinicians completed structured validations, and survey responses indicated favorable perceptions: 93% found the platform intuitive, over 80% would recommend it, and agreement on AI utility exceeded 40% across most endpoints, indicating a positive reception of the AI as a supportive “second reader” tool that prompts clinical re-evaluation rather than simple consensus. Workflow impact was rated positively, underlining the potential to support clinical decision-making. Conclusion: This platform offers a reproducible, scalable, and user-friendly environment for clinical validation of AI models in oncology. Its modular architecture allows integration of additional AI models and is designed to ensure sustainability and interoperability, fostering evidence-based AI adoption in European radiology practice. Trial registration: ClinicalTrials.gov, NCT06950996. Key Points: How can the medical community standardize the in silico clinical validation of oncology AI models to safely bridge the gap before real-world deployment? We successfully implemented a web-based microservices platform, demonstrating high clinical usability and defining human-AI trust dynamics across five distinct cancer types. This standardized validation framework directly enhances diagnostic confidence and interdisciplinary medical collaboration, bridging technical performance with clinical trust to ensure that innovative artificial intelligence technologies safely optimize daily treatment decisions and ultimately maximize therapeutic success and safety for oncology patients.
- Open Access
- 15 July 2025
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 270, 108931
In-silico patient-specific modelling of prostate cancer: Predicting PSA dynamics and treatment response
- 15 July 2025
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 270, 108931
Open AccessIn-silico patient-specific modelling of prostate cancer: Predicting PSA dynamics and treatment response
- Open Access
- 15 December 2021
- Published by MDPI AG in Electronics
- Vol. 10 (24) , 3118
Hardware Architectures for Real-Time Medical Imaging
Medical imaging is considered one of the most important advances in the history of medicine and has become an essential part of the diagnosis and treatment of patients. Earlier prediction and treatment have been driving the acquisition of higher image resolutions as well as the fusion of different modalities, raising the need for sophisticated hardware and software systems for medical image registration, storage, analysis, and processing. In this scenario and given the new clinical pipelines and the huge clinical burden of hospitals, these systems are often required to provide both highly accurate and real-time processing of large amounts of imaging data. Additionally, lowering the prices of each part of imaging equipment, as well as its development and implementation, and increasing their lifespan is crucial to minimize the cost and lead to more accessible healthcare. This paper focuses on the evolution and the application of different hardware architectures (namely, CPU, GPU, DSP, FPGA, and ASIC) in medical imaging through various specific examples and discussing different options depending on the specific application. The main purpose is to provide a general introduction to hardware acceleration techniques for medical imaging researchers and developers who need to accelerate their implementations.
- 15 December 2021
- Published by MDPI AG in Electronics
- Vol. 10 (24) , 3118
Open AccessHardware Architectures for Real-Time Medical Imaging
Medical imaging is considered one of the most important advances in the history of medicine and has become an essential part of the diagnosis and treatment of patients. Earlier prediction and treatment have been driving the acquisition of higher image resolutions as well as the fusion of different modalities, raising the need for sophisticated hardware and software systems for medical image registration, storage, analysis, and processing. In this scenario and given the new clinical pipelines and the huge clinical burden of hospitals, these systems are often required to provide both highly accurate and real-time processing of large amounts of imaging data. Additionally, lowering the prices of each part of imaging equipment, as well as its development and implementation, and increasing their lifespan is crucial to minimize the cost and lead to more accessible healthcare. This paper focuses on the evolution and the application of different hardware architectures (namely, CPU, GPU, DSP, FPGA, and ASIC) in medical imaging through various specific examples and discussing different options depending on the specific application. The main purpose is to provide a general introduction to hardware acceleration techniques for medical imaging researchers and developers who need to accelerate their implementations.